Correlation Between Bristol Myers and Medtronic PLC

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Bristol Myers and Medtronic PLC at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Bristol Myers and Medtronic PLC into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Bristol Myers Squibb and Medtronic PLC, you can compare the effects of market volatilities on Bristol Myers and Medtronic PLC and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Bristol Myers with a short position of Medtronic PLC. Check out your portfolio center. Please also check ongoing floating volatility patterns of Bristol Myers and Medtronic PLC.

Diversification Opportunities for Bristol Myers and Medtronic PLC

-0.45
  Correlation Coefficient

Very good diversification

The 3 months correlation between Bristol and Medtronic is -0.45. Overlapping area represents the amount of risk that can be diversified away by holding Bristol Myers Squibb and Medtronic PLC in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Medtronic PLC and Bristol Myers is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Bristol Myers Squibb are associated (or correlated) with Medtronic PLC. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Medtronic PLC has no effect on the direction of Bristol Myers i.e., Bristol Myers and Medtronic PLC go up and down completely randomly.

Pair Corralation between Bristol Myers and Medtronic PLC

Considering the 90-day investment horizon Bristol Myers Squibb is expected to generate 1.85 times more return on investment than Medtronic PLC. However, Bristol Myers is 1.85 times more volatile than Medtronic PLC. It trades about 0.15 of its potential returns per unit of risk. Medtronic PLC is currently generating about 0.05 per unit of risk. If you would invest  4,069  in Bristol Myers Squibb on August 30, 2024 and sell it today you would earn a total of  1,858  from holding Bristol Myers Squibb or generate 45.66% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Bristol Myers Squibb  vs.  Medtronic PLC

 Performance 
       Timeline  
Bristol Myers Squibb 

Risk-Adjusted Performance

12 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Bristol Myers Squibb are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. In spite of fairly uncertain primary indicators, Bristol Myers showed solid returns over the last few months and may actually be approaching a breakup point.
Medtronic PLC 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Medtronic PLC has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable fundamental indicators, Medtronic PLC is not utilizing all of its potentials. The current stock price uproar, may contribute to short-horizon losses for the private investors.

Bristol Myers and Medtronic PLC Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Bristol Myers and Medtronic PLC

The main advantage of trading using opposite Bristol Myers and Medtronic PLC positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Bristol Myers position performs unexpectedly, Medtronic PLC can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Medtronic PLC will offset losses from the drop in Medtronic PLC's long position.
The idea behind Bristol Myers Squibb and Medtronic PLC pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Dashboard module to portfolio dashboard that provides centralized access to all your investments.

Other Complementary Tools

Money Managers
Screen money managers from public funds and ETFs managed around the world
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities